Seoul National University Hospital
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 501
- Market Cap
- -
- Website
- https://www.snubh.org
Recruiting Blood Donor With Allogeneic Natural Killer Cell
Not Applicable
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Other: Leukapheresis or Plasmapheresis
- First Posted Date
- 2016-03-23
- Last Posted Date
- 2017-07-31
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT02716571
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
IL-2 in Refractory Autoimmune Encephalitis
- First Posted Date
- 2016-03-22
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT02714959
Optimum Hand Position During Cardiopulmonary Resuscitation
Not Applicable
Completed
- Conditions
- Hand PositionCardiopulmonary Resuscitation
- Interventions
- Radiation: low dose chest computed tomography
- First Posted Date
- 2016-03-22
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Seoul National University Bundang Hospital
- Target Recruit Count
- 127
- Registration Number
- NCT02715180
Pharmacokinetic-Pharmacodynamic Relationship of Metformin in Healthy Volunteers
- First Posted Date
- 2016-03-18
- Last Posted Date
- 2016-03-18
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT02712619
Accuracy of Pulse Oximeter With Hypoxemic Measurements
Completed
- Conditions
- Cyanotic Congenital Heart Disease
- First Posted Date
- 2016-03-18
- Last Posted Date
- 2018-04-05
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 280
- Registration Number
- NCT02712606
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Impact of Celecoxib on Electrophysiological Property in Brain of Healthy Volunteer
Phase 1
Completed
- Conditions
- Electrophysiologic Property of Brain
- Interventions
- Drug: PlaceboDrug: Celecoxib
- First Posted Date
- 2016-03-17
- Last Posted Date
- 2017-05-22
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT02711579
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Ideal Depth of Guide Wire for Central Catheterization
Not Applicable
Completed
- Conditions
- Patient Safety During Central Venous Catheterization
- Interventions
- Device: central venous catheterization
- First Posted Date
- 2016-03-17
- Last Posted Date
- 2016-07-11
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 69
- Registration Number
- NCT02711761
- Locations
- π°π·
Seoul National University Boramae Hospital, Seoul, Korea, Republic of
Optimal Timing of Zoster Vaccine After Zoster Illness
Not Applicable
Completed
- Conditions
- Shingles
- Interventions
- Biological: Zostavax
- First Posted Date
- 2016-03-10
- Last Posted Date
- 2017-10-13
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT02704572
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Immunotherapy in Intractable Cryptogenic Epilepsy Patients With Autoimmune Antibody
- First Posted Date
- 2016-03-01
- Last Posted Date
- 2016-03-01
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT02695797
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients
Completed
- Conditions
- Helicobacter Pylori InfectionAtrophic GastritisIntestinal Metaplasia
- First Posted Date
- 2016-02-25
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Seoul National University Bundang Hospital
- Target Recruit Count
- 1450
- Registration Number
- NCT02691637
- Locations
- π°π·
Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath